Revenue: The sum of all revenue fields included for a company's operating activities.
Caris Life Sciences,�Inc. (CAI) had Revenue of $275.36M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$275.36M |
$15.25M |
|
$93.07M |
|
$182.28M |
|
$256.04M |
|
$19.32M |
|
$-2.44M |
|
$16.87M |
|
$16.87M |
|
$15.25M |
|
$15.25M |
|
$15.25M |
|
$15.25M |
|
$19.32M |
|
$26.23M |
|
283.89M |
|
295.14M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$1.07B |
|
$102.30M |
|
$188.35M |
|
$1.26B |
|
$158.95M |
|
$393.18M |
|
$457.20M |
|
$616.14M |
|
$639.48M |
|
$620.14M |
|
$639.48M |
|
286.72M |
|
| Cash Flow Statement Financials | |
$39.11M |
|
$-150.00M |
|
$-21.84M |
|
$800.04M |
|
$667.15M |
|
$-132.89M |
|
$56.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.71 |
|
-- |
|
-- |
|
0.38 |
|
0.61 |
|
66.20% |
|
7.01% |
|
7.01% |
|
-- |
|
6.13% |
|
5.54% |
|
$-10.78M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.67 |
|
2.07 |
|
43.58 |
|
2.38% |
|
2.46% |
|
1.21% |
|
1.48% |
|
$2.23 |
|
$-0.04 |
|
$0.13 |
|